BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2389 related articles for article (PubMed ID: 18472316)

  • 21. Infliximab in the treatment of severe ulcerative colitis: a follow-up study.
    Kohn A; Prantera C; Pera A; Cosintino R; Sostegni R; Daperno M
    Eur Rev Med Pharmacol Sci; 2004; 8(5):235-7. PubMed ID: 15638237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short-term efficacy and long-term outcome of cyclosporine treatment in patients with severe ulcerative colitis.
    Wenzl HH; Petritsch W; Aichbichler BW; Hinterleitner TA; Fleischmann G; Krejs GJ
    Z Gastroenterol; 1998 Apr; 36(4):287-93. PubMed ID: 9612926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Infliximab in the treatment of steroid-dependent ulcerative colitis.
    Armuzzi A; De Pascalis B; Lupascu A; Fedeli P; Leo D; Mentella MC; Vincenti F; Melina D; Gasbarrini G; Pola P; Gasbarrini A
    Eur Rev Med Pharmacol Sci; 2004; 8(5):231-3. PubMed ID: 15638236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of infliximab in steroid-dependent ulcerative colitis patients.
    Gavalas E; Kountouras J; Stergiopoulos C; Zavos C; Gisakis D; Nikolaidis N; Giouleme O; Chatzopoulos D; Kapetanakis N
    Hepatogastroenterology; 2007 Jun; 54(76):1074-9. PubMed ID: 17629042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes of salvage therapy for steroid-refractory acute severe ulcerative colitis: ciclosporin vs. infliximab.
    Croft A; Walsh A; Doecke J; Cooley R; Howlett M; Radford-Smith G
    Aliment Pharmacol Ther; 2013 Aug; 38(3):294-302. PubMed ID: 23786158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclosporine or infliximab as rescue therapy in severe refractory ulcerative colitis: early and long-term data from a retrospective observational study.
    Mocciaro F; Renna S; Orlando A; Rizzuto G; Sinagra E; Orlando E; Cottone M
    J Crohns Colitis; 2012 Jul; 6(6):681-6. PubMed ID: 22398101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous cyclosporine for the treatment of severe steroid refractory ulcerative colitis: what is the cost?
    Poritz LS; Rowe WA; Swenson BR; Hollenbeak CS; Koltun WA
    Dis Colon Rectum; 2005 Sep; 48(9):1685-90. PubMed ID: 16007496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive factors of response to cyclosporine in steroid-refractory ulcerative colitis.
    Cacheux W; Seksik P; Lemann M; Marteau P; Nion-Larmurier I; Afchain P; Daniel F; Beaugerie L; Cosnes J
    Am J Gastroenterol; 2008 Mar; 103(3):637-42. PubMed ID: 18047542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Infliximab in ulcerative colitis: the impact of preoperative treatment on rates of colectomy and prescribing practices in the province of British Columbia, Canada.
    Moore SE; McGrail KM; Peterson S; Raval MJ; Karimuddin AA; Phang PT; Bressler B; Brown CJ
    Dis Colon Rectum; 2014 Jan; 57(1):83-90. PubMed ID: 24316950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of anti-tumor necrosis factor therapy in patients with ulcerative colitis.
    Su C; Salzberg BA; Lewis JD; Deren JJ; Kornbluth A; Katzka DA; Stein RB; Adler DR; Lichtenstein GR
    Am J Gastroenterol; 2002 Oct; 97(10):2577-84. PubMed ID: 12385442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of acute severe ulcerative colitis.
    Van Assche G; Vermeire S; Rutgeerts P
    Gut; 2011 Jan; 60(1):130-3. PubMed ID: 21030524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term outcome of ulcerative colitis in patients who achieve clinical remission with a first course of corticosteroids.
    Garcia-Planella E; Mañosa M; Van Domselaar M; Gordillo J; Zabana Y; Cabré E; López San Román A; Domènech E
    Dig Liver Dis; 2012 Mar; 44(3):206-10. PubMed ID: 22079262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adalimumab induction and maintenance therapy for patients with ulcerative colitis previously treated with infliximab.
    Taxonera C; Estellés J; Fernández-Blanco I; Merino O; Marín-Jiménez I; Barreiro-de Acosta M; Saro C; García-Sánchez V; Gento E; Bastida G; Gisbert JP; Vera I; Martinez-Montiel P; Garcia-Morán S; Sánchez MC; Mendoza JL
    Aliment Pharmacol Ther; 2011 Feb; 33(3):340-8. PubMed ID: 21133961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Frequency and predictive factors of colectomy and restorative colo-proctectomy in ulcerative colitis].
    Karoui S; Serghini M; Chaieb M; Jomni T; Kallel L; Fekih M; Matri S; Boubaker J; Filali A
    Tunis Med; 2009 Feb; 87(2):115-9. PubMed ID: 19522443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Infliximab as rescue medication for patients with severe ulcerative/indeterminate colitis refractory to tacrolimus.
    Herrlinger KR; Barthel DN; Schmidt KJ; Büning J; Barthel CS; Wehkamp J; Stange EF; Fellermann K
    Aliment Pharmacol Ther; 2010 May; 31(9):1036-41. PubMed ID: 20175769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of acute ulcerative colitis with infliximab, a retrospective study from three Danish hospitals.
    Mortensen C; Caspersen S; Christensen NL; Svenningsen L; Thorsgaard N; Christensen LA; Bendtsen F
    J Crohns Colitis; 2011 Feb; 5(1):28-33. PubMed ID: 21272801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A fulminant colitis index greater or equal to 8 is not predictive of colectomy risk in infliximab-treated moderate-to-severe ulcerative colitis attacks.
    Baudet A; Colombel JF; Cortot A; Dupas JL; Brazier F; Savoye G; Lerebours E; Justum AM; Reimund JM
    Gastroenterol Clin Biol; 2010 Nov; 34(11):612-7. PubMed ID: 20832218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgical outcomes in steroid refractory acute severe ulcerative colitis: the impact of rescue therapy.
    Powar MP; Martin P; Croft AR; Walsh A; Petersen D; Stevenson AR; Lumley JW; Stitz RW; Radford-Smith GL; Clark DA
    Colorectal Dis; 2013 Mar; 15(3):374-9. PubMed ID: 22849324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successive treatment with cyclosporine and infliximab in steroid-refractory ulcerative colitis.
    Leblanc S; Allez M; Seksik P; Flourié B; Peeters H; Dupas JL; Bouguen G; Peyrin-Biroulet L; Duclos B; Bourreille A; Dewit O; Bouhnik Y; Michetti P; Chaussade S; Saussure P; Mary JY; Colombel JF; Lémann M;
    Am J Gastroenterol; 2011 Apr; 106(4):771-7. PubMed ID: 21386832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: early and late outcome and predictors of colectomy.
    Monterubbianesi R; Aratari A; Armuzzi A; Daperno M; Biancone L; Cappello M; Annese V; Riegler G; Orlando A; Viscido A; Meucci G; Gasbarrini A; Guidi L; Lavagna A; Sostegni R; Onali S; Papi C; Kohn A;
    J Crohns Colitis; 2014 Aug; 8(8):852-8. PubMed ID: 24472490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 120.